GLIBENCLAMIDE PHARMACOKINETICS IN ACARBOSE-TREATED TYPE-2 DIABETICS

被引：21

作者：

GERARD, J

LEFEBVRE, PJ

LUYCKX, AS

机构：

[1] UNIV LIEGE,INST MED,DIV DIABET,B-4000 LIEGE,BELGIUM

[2] UNIV LIEGE,INST MED,DIV CLIN PHARMACOL,B-4000 LIEGE,BELGIUM

来源：

EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY | 1984年 / 27卷 / 02期

关键词：

D O I：

10.1007/BF00544051

中图分类号：

R9 [药学];

学科分类号：

1007 ;

摘要：

引用

页码：233 / 236

页数：4

共 16 条

[1]

AUBELL R, 1982, 1ST P INT S AC MONTR, P363

[2]

CREUTZFELDT W, 1982, EXCERPTA MED ICS, V594

[3]

GERARD J, 1981, DIABETOLOGIA, V21, P446, DOI 10.1007/BF00257784

[4] IMMUNOASSAY OF INSULIN WITH INSULIN-ANTIBODY PRECIPITATE [J].

HALES, CN ;

RANDLE, PJ .

BIOCHEMICAL JOURNAL, 1963, 88 (01) :137-&

[5]

HILLEBRAND I, 1981, DIABETOLOGIA, V21, P282

[6]

LEFEBVRE PJ, 1976, DIABETES METAB, V2, P15

[7]

LUYCKX AS, 1972, GLUCAGON MOL PHYSL C, P285

[8]

MALANGEAU P, 1963, ANN BIOL CLIN, V21, P1

[9] GLUCOSIDASE INHIBITION - NEW APPROACH TO TREATMENT OF DIABETES, OBESITY, AND HYPERLIPOPROTEINEMIA [J].

PULS, W ;

KEUP, U ;

KRAUSE, HP ;

THOMAS, G ;

HOFFMEISTER, F .

NATURWISSENSCHAFTEN, 1977, 64 (10) :536-537

[10]

SACHSE G, 1979, DIABETOLOGIA, V17, P187

← 1 2 →